Depressive symptoms linked to 1-h plasma glucose concentrations during the oral glucose tolerance test in men and women with the metabolic syndrome

Diabetic Medicine

Volumn 31, Issue 5, 2014, Pages 630-636

  Birnbaum Weitzman, O ^a,b   Goldberg, R ^a,c   Hurwitz, B E ^a,b,c   Llabre, M M ^a,b   Gellman, M D ^a,b   Gutt, M ^c   Mccalla, J R ^b   Mendez, A J ^a,c   Schneiderman, N ^a,b,c  

^a UNIVERSITY OF MIAMI   (United States)

^b University of Miami   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGIC TEST; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME;

ADULT; AGED; BLOOD GLUCOSE; DEPRESSION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84898866286     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12356     Document Type: Article

References (30)

1. Kan C, Silva N, Golden SH, Rajala U, Timonen M, Stahl D et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013; 36: 480-489.
2. Shomaker LB, Tanofsky-Kraff M, Stern EA, Miller R, Zocca JM, Field SE et al. Longitudinal study of depressive symptoms and progression of insulin resistance in youth at risk for adult obesity. Diabetes Care 2011; 34: 2458-2463.
3. Okamura F, Tashiro A, Utumi A, Imai T, Suchi T, Tamura D et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000; 49: 1255-1260.
4. Wagner J, Allen NA, Swalley LM, Melkus GD, Whittemore R. Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes. Diabetes Res Clin Pract 2009; 86: 96-103.
5. Lustman PJ, Clouse RE. Depression in diabetes: the chicken or the egg? Psychosom Med 2007; 69: 297-299.
6. Knol MJ, Heerdink ER, Egberts AC, Geerlings MI, Gorter KJ, Numans ME et al. Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med 2007; 69: 300-305.
7. Mantyselka P, Korniloff K, Saaristo T, Koponen H, Eriksson J, Puolijoki H et al. Association of depressive symptoms with impaired glucose regulation, screen-detected, and previously known type 2 diabetes: findings from the Finnish D2D Survey. Diabetes Care 2011; 34: 71-76.
8. Nouwen A, Nefs G, Caramlau I, Connock M, Winkley K, Lloyd CE et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care 2011; 34: 752-762.
9. Rhee MK, Musselman D, Ziemer DC, Vaccarino V, Kolm P, Weintraub WS et al. Unrecognized glucose intolerance is not associated with depression. Screening for Impaired Glucose Tolerance study 3 (SIGT 3). Diabet Med 2008; 25: 1361-1365.
10. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708-723.
11. Abdul-Ghani MA, Stern MP, Lyssenko V, Tuomi T, Groop L, Defronzo RA. Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose. Diabetes Care 2010; 33: 557-561.
12. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007; 30: 1544-1548.
13. Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 2009; 32: S194-198.
14. Zhou W, Gu Y, Li H, Luo M. Assessing 1-h plasma glucose and shape of the glucose curve during oral glucose tolerance test. Eur J Endocrinol 2006; 155: 191-197.
15. Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008; 31: 1650-1655.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005; 13: 322-327.
17. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
18. Steer RA, Brown GK, Beck AT, Sanderson WC. Mean Beck Depression Inventory-II scores by severity of major depressive episode. Psychol Rep 2001; 88: 1075-1076.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. 0, 120): comparison with other measures. Diabetes Res Clin Pract 2000; 47: 177-184.
21. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000; 151: 190-198.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
23. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods 2002; 7: 147-177.
24. Suarez EC. Sex differences in the relation of depressive symptoms, hostility, and anger expression to indices of glucose metabolism in nondiabetic adults. Health Psychol 2006; 25: 484-492.
25. Manco M, Panunzi S, Macfarlane DP, Golay A, Melander O, Konrad T et al. One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care 2010; 33: 2090-2097.
26. Skaff MM, Mullan JT, Almeida DM, Hoffman L, Masharani U, Mohr D et al. Daily negative mood affects fasting glucose in type 2 diabetes. Health Psychol 2009; 28: 265-272.
27. Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012; 35: 1171-1180.
28. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 2002; 287: 356-359.
29. Shen BJ, Goldberg RB, Llabre MM, Schneiderman N. Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study. Ann Epidemiol 2006; 16: 131-137.
30. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976-1980.